Exacerbation Reduction in Patients with Asthma Following Escalation to FF/UMEC/VI from ICS/LABA: Retrospective Cohort Study.

Saved in:
Bibliographic Details
Title: Exacerbation Reduction in Patients with Asthma Following Escalation to FF/UMEC/VI from ICS/LABA: Retrospective Cohort Study.
Authors: Baptist AP; Division of Allergy and Clinical Immunology, Henry Ford Health and MI State University Health Sciences, Detroit, MI, USA., Paczkowski R; Global Real-World Evidence and Health Outcomes Research Organization, GSK, Collegeville, PA, USA., Germain G; Group d'Analyse, SRI Ltée, Montréal, QC, Canada., Klimek J; Analysis Group, Inc, Boston, MA, USA., Laliberté F; Group d'Analyse, SRI Ltée, Montréal, QC, Canada., Schell RC; Analysis Group, Inc, Menlo Park, CA, USA., Forero-Schwanhaeuser S; US Medical Affairs, GSK, Durham, NC, USA., Moore A; Global Medical Affairs, General Medicines, GSK, London, UK., Noorduyn SG; Global Real-World Evidence and Health Outcomes Research Organization, GSK, 100 Milverton Drive, Suite 800, Mississauga, ON, L5R 4H1, Canada. stephen.g.noorduyn@gsk.com.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada. stephen.g.noorduyn@gsk.com.
Source: Pulmonary therapy [Pulm Ther] 2025 Dec; Vol. 11 (4), pp. 725-740. Date of Electronic Publication: 2025 Oct 28.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101687144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2364-1746 (Electronic) Linking ISSN: 23641754 NLM ISO Abbreviation: Pulm Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2364-1746
DOI:10.1007/s41030-025-00327-w